Anmeldung erfolgt in Kürze...
Details werden geladen...
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
Clinical, safety and translational data presented at EULAR 2026 reinforced AlloNK®’s potential to drive deep B-cell depletion and meaningful clinical activity, with a tolerability profile supportive of outpatient administration
Ähnliche Seiten
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/avalyn-reports-first-quarter-2026-financial-results-and-recent-business-highlights/2357667
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/geron-corporation-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2398831Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/aspen-aerogels-inc-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2399833EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/eyepoint-reports-second-quarter-2026-financial-results-and-highlights-recent-corporate-developments/2398832Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights | The Manila Times
https://www.manilatimes.net/2026/07/30/tmt-newswire/globenewswire/dyne-therapeutics-reports-second-quarter-2026-financial-results-and-recent-business-highlights/2394460